THE IMPORTANCE OF NOOTROPIC DRUGS IN MEDICAL PRACTICE AND THE RELEVANCE OF THEIR IMPROVEMENT

Pakhlavon Qakhramonovich Turdiev,  Nosirova Matluba Ravshan kizi, Khajibaeva Madina Khursand kizi,  Mo‘ydinova Madinabonu Ilkhomjon kizi ,  To‘rajonova Musaffo Alijon kizi ,  Khamraeva Marjona Sherali kizi

Authors

Pakhlavon Qakhramonovich Turdiev, Nosirova Matluba Ravshan kizi, Khajibaeva Madina Khursand kizi, Mo‘ydinova Madinabonu Ilkhomjon kizi , To‘rajonova Musaffo Alijon kizi , Khamraeva Marjona Sherali kizi Head teacher of the Department of Pharmacology of Tashkent State Medical University, Tashkent, Uzbekistan. Teacher at the Department of Surgical Sciences, Faculty of Medicine, Namangan State ,Student of the group 303B, 3nd Faculty of General Medicine of Tashkent State Medical University, Tashkent, Uzbekistan. Student of the group 305B, 3nd Faculty of General Medicine of Tashkent State Medical University, Tashkent, Uzbekistan. Student of the group 307B, 3nd Faculty of General Medicine of Tashkent State Medical University, Tashkent, Uzbekistan. Student of the group 105A, 2nd Faculty of Dentistry of Tashkent State Medical University, Tashkent, Uzbekistan.

Keywords:

Learning, antioxidant action, brain damage, piracetam, Panax ginseng, nootropics, memory, Paullinia cupana, and ayurvedic.

Abstract

Nootropics, also known as “smart drugs” are a diverse group of medicinal substances whose action improves human thinking, learning, and memory, especially in cases where these functions are impaired. This review provides an up-to-date overview of the potential effectiveness and importance of nootropics. Based on their nature and their effects, this heterogeneous group of drugs has been divided into four subgroups: classical nootropic compounds, substances increasing brain metabolism, cholinergic, and plants and their extracts with nootropic effects. Many healthy people increasingly utilize "smart drugs" to try to improve their mental function, even though nootropics are intended to address cognitive issues associated with medical disorders. The clinical concerns around common nootropics and other drugs used for this purpose are reviewed in this paper. It is difficult to determine how effective these medications are as supplements or therapies because research on them varies widely, particularly for age-related brain diseases. The applications, indications, experimental treatments, dosage, potential side effects, and contraindications are covered for each of the numerous primary representatives of each class of nootropics. A brief explanation of each plant representative, including its occurrence, history, and chemical makeup of the therapeutic part, is also included for the nootropic plant extracts. Finally, detailed guidelines for the usage of nootropics by healthy and sick people are outlined. Methylphenidate, modafinil, amphetamines, and psychedelics are the most popular smart drugs, which are frequently taken under pressure or stress at work or school. The effectiveness of these medications in enhancing cognitive and decision-making abilities is still unknown, though. There are health dangers associated with using them, particularly if you don't have a prescription. Additionally, there is a dearth of up-to-date, comprehensive information regarding the prevalence of these substances and their effects. Improved training for physicians, pharmacists, and other healthcare professionals may assist identify issues early and increase patient safety.

References

Malík M, Tlustoš P. Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs. Nutrients. 2022 Aug 17;14(16):3367. doi: 10.3390/nu14163367.

Schifano F, Bonaccorso S, Arillotta D, Corkery JM, Floresta G, Papanti Pelletier GD, Guirguis A. Focus on Cognitive Enhancement: A Narrative Overview of Nootropics and "Smart Drug" Use and Misuse. Biology (Basel). 2025 Sep 11;14(9):1244. doi: 10.3390/biology14091244.

Aripov A.N., Aripov O.A., Akhundjanova L.L., Nabiev A.U., Nabieva D.A., & Khamroev T.T. (2022). Study the effect of yantacin on some indicators of cellular renewal and on the level of protein expression on rat hepatocytes in chronic heliotrine liver damage. International Journal of Medical Sciences And Clinical Research, 2(05), 06–13. https://doi.org/10.37547/ijmscr/Volume02Issue05-02.

Aripov A. N, Akhunzhanova L. L, Nabiev A. U, Aripov A. O, Khamroev T. T.. Antifibrotic Efficacy of a New Phytocomposition of Essential Phospholipids with Glycyrrhizic Acid, Ecdysterone, Lycopene and Proanthacyanidin in Experimental Severe Chronic Hepatitis Compared with Phosphogliv. Biomed Pharmacol J 2023;16(3).Pages : 1815-1825. DOI : https://dx.doi.org/10.13005/bpj/2761

Aripov A.N, Akhunjanova L.L, Khamroev T.T, Aripov Abdumalik Nigmatovich, Akhunjanova Lola Lazizovna, & Khamroev Tolmas Tolibovich. (2022). Differential Analysis of Chronic Toxic Hepatitis Caused by The Introduction of Heliotrin Solution in Various Ways. Texas Journal of Medical Science, 4, 58–62. Retrieved from https://zienjournals.com/index.php/tjms/article/view/670

Rashidov S.Z., Rakhimboev S.D., Sanoev Z.I., Abdinazarov I.T., Khamroev T.T., Ismailova D.S., & Elmuradov B.J.. (2022). Study of psychoactive activity potassium salt 5-(o-aminophenyl)-1,3,4- oxadiazole-2-thion (D-361). International Journal of Medical Sciences And Clinical Research, 2(09), 1–5. https://doi.org/10.37547/ijmscr/Volume02Issue09-01

Арипов А.Н., Арипов О.А., Ахунджанова Л.Л., Набиев А.Ў., Нишанбаев С.З., Набиева Д.А., Ҳамроев Т.Т. Тажриба шароитида сафорофлавонолозиднинг гепатотроп фаоллигини ўрганиш. Oriental Journal of Medicine and Pharmacology, 2(02), 55–64. https://doi.org/10.37547/supsci-ojmp-02-02-07

Zakhidova L.T., Saidkhodjaeva D.M., Sanoev Z.I., Tukhtasheva V.F., Rakhmanova H.A.., Hamroyev T.T. Toxicological Characteristics Of N-Deacetyllappaconitine Under Chronic Administration In White Rats. The American Journal of Applied Sciences, 3(03), 34-41. https://doi.org/10.37547/tajas/Volume03Issue03-06

Khamroev T.T., Sanoev Z.I., Rakhimboev S.D., Abdinazarov I.T., Rashidov S.Z. Effect of antiarrhythmic substance N – dezacetyllapoconitin on the central nervous system. ISJ Theoretical &Applied Science, 07 (99), 153-157. http://soi.org/1.1/TAS-07-99-31 Doi:https://dx.doi.org/10.15863

Sanoev Z. I, Ismailova D. S, Rakhimboev S. D. O, Khamroev T, T, Elmuradov B. Z, Abdinazarov I. T, Rashidov S. Z. O. Synthesis and Research Anticonvulsant Activity of Annulated Triazolo-Thiadiazine Derivative in Laboratory Animals. Biomed Pharmacol J 2023;16(4). DOI : https://dx.doi.org/10.13005/bpj/2820

Sokhib Rashidov Zamon oʻgʻli, Muslimakhon Kamolova Mirzokhidjon qizi, Ikhvoliddin Mirzaev Komiljon o‘g‘li, Nodira Pardaeva Botir qizi, Sevara Rakhmatullaeva Shukhrat qizi/. (2025). The importance of cardiotonic drugs in medical practice, the range of applications and the advantages of their use. International Journal of Cognitive Neuroscience and Psychology, 3(5), 95–100. Retrieved from https://medicaljournals.eu/index.php/IJCNP/article/view/1856

Sanoev Zafar Isomiddinovich, Rashidov Sokhib Zamon ugli, Raximboev Sukhrob Davlatyor ugli, Abdinazarov Ibrokhim Tuychievich, Khamroev Tolmas Tolibovich, Ismailova Dilnoza Safaralievna, & Elmuradov Burkhon Juraevich. (2022). Research of Anticonvulsant Activity of Compound 5- (P-Aminophenyl) - 1,3,4-Oxadiazole-2-Thion. Texas Journal of Medical Science, 13, 17–21. Retrieved from https://zienjournals.com/index.php/tjms/article/view/2434

Yu. R. Mirzaev, T. T. Khamroev, E. M. Ruzimov, B. N. Khandamov, & Sh. M. Adizov. (2022). Evaluation of the Effect on the Nervous System of Substances with an Alkaloid Structure Having Antitumor Activity. Journal Healthcare Treatment Development(JHTD) ISSN : 2799-1148, 2(06), 6–10. Retrieved from http://journal.hmjournals.com/index.php/JHTD/article/view/1577

Aripov A.N., Aripov O.A., Akhunjanova L.L., Nabiev A.O., Nabieva D.A., & Khamroev T.T. (2022). Study the antifibrous efficacy of plant proanthocyanidin in rats with chronic heliotrine liver damage. Frontline Medical Sciences and Pharmaceutical Journal, 2(05), 16–25. https://doi.org/10.37547/medical-fmspj-02-05-03.

Murphy, R.J.; Muthukumaraswamy, S.; de Wit, H. Microdosing Psychedelics: Current Evidence From Controlled Studies. Biol. Psychiatry Cogn. Neurosci. Neuroimaging 2024, 9, 500–511.

Sokhib Rashidov Zamon oʻgʻli, Nilufar Ergasheva Agʼzamjon qizi, Elyor Zokirboyev Anvarjon o‘gli, Umidjon Akramov Abdusamad o‘g‘li, & Aziza Egamberdieva Farkhod qizi. (2025). Drugs That Increase the Tone of the Human Body and Pharmacological Characteristics of Immunodeficiency Agents. American Journal of Biomedicine and Pharmacy, 2(5), 300–306. Retrieved from https://biojournals.us/index.php/AJBP/article/view/1065

Glazer, J.; Murray, C.H.; Nusslock, R.; Lee, R.; de Wit, H. Low Doses of Lysergic Acid Diethylamide (LSD) Increase Reward-Related Brain Activity. Neuropsychopharmacology 2023, 48, 418–426.

Sokhib Rashidov Zamon oʻgʻli, Murodjon Nabiev Mahammadkarim o‘g‘li, Mo'tabar Yoqubjonova Khusanboy qizi, Shakhzodakhon Bekmurodova Poʻlatjon qizi, & Jumanazar To‘ychiev Saidqul o‘g‘li. (2025). Comparative Analysis of Drugs Used for Anemia and Drugs Storing Iron. Research Journal of Trauma and Disability Studies, 4(5), 190–195. Retrieved from https://journals.academiczone.net/index.php/rjtds/article/view/5141

Sokhib Rashidov Zamon oʻgʻli, Shakhzoda Abduraimova Abdusattor qizi, Nigora Yusufjonova Mirrakhim qizi, Diyora Turdibekova Erkinjon qizi, & Makhsuma Dovutkho’jayeva Maqsudjonovna. (2025). Classification, Indications for Use, Range of Applications and Disadvantages of Medicines against Nematodes and Leishmania. Research Journal of Trauma and Disability Studies, 4(5), 196–201. Retrieved from https://journals.academiczone.net/index.php/rjtds/article/view/5142

Sokhib Rashidov Zamon oʻgʻli, Nigora Yusufjonova Mirrakhim qizi, Diyora Turdibekova Erkinjon qizi, Makhsuma Dovutkho’jaeva Maqsudjonovna, Shakhzoda Abduraimova Abdusattor qizi, Analysis of the effect of medicines used in medical practice for various diseases on the fetus , european journal of modern medicine and practice: Vol. 5 No. 5 (2025) 342-347.

Sokhib Rashidov Zamon oʻgʻli, Elyor Zokirboev Anvarjon ògli, Umidjon Akramov Abdusamad o‘g‘li, Aziza Egamberdiyeva Farkhod qizi, Munisa Qoʻshbekova Roʻzimbek qizi. (2025). Analysis of general and specific pharmacological properties of fat-soluble vitamins. International Journal of Cognitive Neuroscience and Psychology, 3(5), 101–106. Retrieved from https://medicaljournals.eu/index.php/IJCNP/article/view/1857

Schifano F, Bonaccorso S, Arillotta D, Corkery JM, Floresta G, Papanti Pelletier GD, Guirguis A. Focus on Cognitive Enhancement: A Narrative Overview of Nootropics and “Smart Drug” Use and Misuse. Biology. 2025; 14(9):1244. https://doi.org/10.3390/biology14091244

Nguyen, L.A.M.; Simons, C.W.; Thomas, R. Nootropic Foods in Neurodegenerative Diseases: Mechanisms, Challenges, and Future. Transl. Neurodegener. 2025, 14, 17.

Lugg, W. Cosmetic Psychiatry: A Concept in Urgent Need of Consideration. Australas. Psychiatry 2024, 32, 32–37.

Floresta, G.; Catalani, V.; Abbate, V. Evidence-Based Successful Example of a Structure-Based Approach for the Prediction of Designer Fentanyl-like Molecules. Emerg. Trends Drugs Addict. Health 2024, 4, 100143.

Schifano, F.; Catalani, V.; Sharif, S.; Napoletano, F.; Corkery, J.M.; Arillotta, D.; Fergus, S.; Vento, A.; Guirguis, A. Benefits and Harms of “Smart Drugs” (Nootropics) in Healthy Individuals. Drugs 2022, 82, 633–647.

Yamamoto, M. Pharmacological Cognitive Enhancement: Current Situation and Perspectives. Yakugaku Zasshi J. Pharm. Soc. Jpn. 2022, 142, 521–526.

Cornejo-Plaza, M.I.; Saracini, C. On Pharmacological Neuroenhancement as Part of the New Neurorights’ Pioneering Legislation in Chile: A Perspective. Front. Psychol. 2023, 14, 1177720.